3D Systems (DDD) investor relations material

Executive summary

• Q2 2026 revenue was $94.6 million, up 1.4% year-over-year excluding divestitures, driven by strong hardware printer sales and robust demand in Med Tech, Dental, Aerospace & Defense, and Data Center Infrastructure.

• Adjusted EBITDA improved to $(0.8) million, reflecting higher revenue, cost discipline, and operational efficiencies.

• The company announced a CEO succession plan and completed a leadership transition announcement.

• Strategic partnership with Savannah River National Laboratory was announced to advance nuclear and fusion energy applications.

• Net loss attributable to shareholders was $(12.9) million for Q2 2026, compared to net income of $104.4 million in Q2 2025, which included a $125.7 million gain from the Geomagic divestiture.

Financial highlights

• Q2 2026 revenue: $94.6 million, up 1.4% year-over-year excluding divestitures; Healthcare at $48.1 million (up 6.8%), Industrial at $46.5 million (down 6.7%).

• Non-GAAP gross margin: 36.7%, impacted by higher hardware mix and less favorable materials mix, partially offset by $2.6 million in tariff refunds.

• Operating expenses decreased to $39.5 million non-GAAP (down 11% YoY); GAAP operating expenses were $45.1 million.

• Adjusted EBITDA: $(0.8) million, a $4.6 million improvement year-over-year.

• Cash and equivalents at Q2 end: $128–129 million; total debt: $96 million; $53.2 million raised via equity offering.

Outlook and guidance

• Q3 2026 revenue guidance: $96–$99 million; Adjusted EBITDA guidance: $(3) million to $(1) million.

• Continued strength anticipated in key markets, with growth in printer hardware and parts sales, and ongoing adoption of the denture platform.

• Management expects sufficient liquidity for the next twelve months, supported by cash, cash equivalents, and anticipated cash flow from operations.